Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
GLP-1 and MASH: When weight loss isn’t the whole story
Long MT, Krarup N, Knop FK
Cell metabolism;38(7):1258-1260
Real-World vs. Randomized Trial Evidence for Incretin-Based Therapies: A Narrative Review
Bloomgarden Z
Journal of diabetes;18(7):e70248
Pharmacological Interventions for Weight Reduction in Patients With Schizophrenia Treated With Antipsychotics: A Systematic Review and Network Meta-Analysis
Stogios N, Agarwal SM, Maksyutynska K, et al.
JAMA psychiatry, 2026
Disrupting the adiposopathy-inflammation loop: a translational immunometabolic framework for inflammatory disease
Corrao S
Journal of translational medicine, 2026
Comparative effectiveness of tirzepatide and DPP-4 inhibitors in type 2 diabetes with heart failure
Mortada I, Paul K, Chammany M, et al.
Diabetes & vascular disease research, 2026;23(4):14791641261467888
Neuropsychiatric Outcomes With Tirzepatide, Semaglutide, and Other GLP-1 Receptor Agonists
Chen SC, Wang TJ, Chou CK, et al.
Diabetes, obesity & metabolism, 2026
Real-World Use of Semaglutide for Weight Management: Dose Titration, Discontinuation Patterns and Weight Changes
Skandov MD, Christensen KM, Dalin DA, et al.
Diabetes, obesity & metabolism, 2026
Short-Term HbA1c Non-Inferiority of Synthetic Semaglutide Should Not Be Conflated With Full Therapeutic Interchangeability
Singh AK, Singh A, Singh R
Diabetes, obesity & metabolism, 2026
Glucagon-like peptide-1 receptor agonists for weight management in mental illness: a network meta-analysis
Kishi T, Ikuta T, Sakuma K, et al.
Translational psychiatry, 2026
Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis
Nong K, Shi Q, Xie X, et al.
BMJ (Clinical research ed.), 2026;394:e372161
The Neuroendocrine-Appetite-Mental Health Triangle in PMOS: Implications for GLP-1 Receptor Agonist Therapy
Xu W, Lu C, Xu J, et al.
Neuroscience and biobehavioral reviews, 2026;:106846
GLP-1R and GIPR crosstalk modulates insulinotropic signaling pathways
Lindquist P, Dijkhof LRH, Drzazga AK, et al.
Cell chemical biology, 2026
Effects of tirzepatide therapy on body weight and body composition in adults with overweight and obesity
Corso H, Graybeal AJ, Hoelscher E, et al.
Frontiers in endocrinology, 2026;17:1834580
Personalization of incretin therapy: can GLP-1 and GIP receptor polymorphisms influence therapy response?
La Vignera S, Condorelli RA
Journal of the Endocrine Society, 2026;10(8):bvag149
Incretin-Based Therapies in Sports: Pharmacological Mechanisms, Performance-Enhancing Potential, and Anti-Doping Implications-A Narrative Review
La Vignera S, Condorelli RA
International journal of molecular sciences, 2026;27(14)
A tea exosome-integrated self‑oxygenating cascade chitosan/oxidized alginate hydrogel for remodeling the hyperglycemic and hypoxic microenvironment in diabetic wound healing
Xie LH, Zhou XH, Wen WQ, et al.
Carbohydrate polymers, 2026;389:125628
Semaglutide Modulates Visceral Adipose Tissue Lipid Metabolism in Type 2 Diabetic Mice: A Lipidomics Study
Chen X, Tu B, Li Z, et al.
Frontiers in bioscience (Landmark edition);31(6):49873
Harnessing the Reactivity of Sulfinate Salts With Cystine: An Umpolung Approach to Residue-Specific Peptide Modification
Hammond JM, Suárez-Picado E, von Sydow L, et al.
Angewandte Chemie (International ed. in English), 2026;:e5484068
Sirtuin 1 deficiency mediates chronic kidney disease-induced inflammaging cardiovascular calcification
Xu L, Zheng Y, Liu M, et al.
Molecular biomedicine, 2026;7(1)
Effects of Tirzepatide in Obesity-Related HFpEF by Sex: A Prespecified Secondary Analysis From the SUMMIT Trial
Borlaug BA, Zile MR, Kramer CM, et al.
JACC. Heart failure, 2026;:103218